Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to -$10.3 million.

  • GoHealth's Other Working Capital Changes fell 23476.5% to -$10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year decrease of 6897.56%. This contributed to the annual value of -$15.0 million for FY2024, which is 7125.19% down from last year.
  • Latest data reveals that GoHealth reported Other Working Capital Changes of -$10.3 million as of Q3 2025, which was down 23476.5% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, GoHealth's Other Working Capital Changes registered a high of $29.1 million during Q4 2021, and its lowest value of -$33.5 million during Q1 2023.
  • Its 5-year average for Other Working Capital Changes is -$1.6 million, with a median of -$7.3 million in 2024.
  • In the last 5 years, GoHealth's Other Working Capital Changes skyrocketed by 19121.03% in 2021 and then plummeted by 23476.5% in 2025.
  • Over the past 5 years, GoHealth's Other Working Capital Changes (Quarter) stood at $29.1 million in 2021, then decreased by 20.88% to $23.0 million in 2022, then increased by 12.56% to $25.9 million in 2023, then crashed by 47.14% to $13.7 million in 2024, then plummeted by 175.17% to -$10.3 million in 2025.
  • Its Other Working Capital Changes stands at -$10.3 million for Q3 2025, versus $1.5 million for Q2 2025 and -$9.6 million for Q1 2025.